3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Vomiting
3
Nausea
3
Neoplasms
2
Prostatic Neoplasms
1
Lymphoma
1
Leukemia
1
Interventions
nilotinib
4
Cytarabine
3
Filgrastim
2
Cyclophosphamide
2
Aprepitant
2
Antilymphocyte Serum
2
rasburicase
1
liposomal amphotericin B
1
fludarabine phosphate
1
fludarabine
1
bosutinib
1
blinatumomab
1
aldesleukin
1
Water
1
Voriconazole
1
Urate Oxidase
1
Tobacco Use Cessation Devices
1
Thiotepa
1
Rituximab
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Prilocaine
1
Polymerase Chain Reaction
1
Pharmacogenomic Testing
1
Pentostatin
1
Palonosetron
1
Oxygen
1
Interleukin-2
1
Inotuzumab Ozogamicin
1
Histamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Leukemia
×
Granisetron
×
Clear all
NCT00415103
2009-09-18
AMENO-2
PETHEMA Foundation
Phase 4
Completed
196 enrolled